Researchers report promising results from a clinical trial of rapamycin against aging
Researchers have just published promising clinical trial results for rapamycin in the first-ever test of its safety and antiaging effects on Senior adults. This article was originally published on LongevityFacts. Brady Hartman is the author.
Rapamycin was tested on healthy adults in a recent clinical trial. The results showed that the drug is safe to use for anti-aging over the short term.
The rapamycin clinical trial was the first to test the safety of this compound as an anti-aging medication in Seniors who were healthy. This clinical trial involved 25 older adults aged 70-95 who were healthy. Participants in the study were given either a 1mg daily rapamycin or a placebo for 8 weeks. The study’s main conclusion was that the drug is safe and has no significant side effects. Researchers published their findings on February 3, in the journal Experimental Gerontology, and concluded.